HOME
ABOUT ZOGENIX
PRODUCT CANDIDATES & TECHNOLOGY
CURRENT INVESTORS
NEWS
CAREERS
CONTACT US
Archive for March, 2008
Zogenix, Inc. Files Registration Statement for Proposed Initial Public Offering
Monday, March 24th, 2008
(more…)
Posted in
news
|
No Comments »
Zogenix Announces
sumatriptan
DosePro™ NDA Accepted for Filing by FDA
Wednesday, March 19th, 2008
(more…)
Posted in
news
|
No Comments »
Zogenix Licenses European Development and Commercial Rights for
sumatriptan
DosePro™ to Desitin Pharmaceuticals, GmbH
Monday, March 17th, 2008
(more…)
Posted in
news
|
No Comments »